A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified the specific cells responsible ...

An AI model significantly improved recurrence risk stratification vs. recurrence score among patients with hormone ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask ...

If your cancer has come back, your doctor might suggest a biopsy to verify that it’s a recurrence instead of a second cancer.

Primary disease recurrence after renal transplantation accounts for 7–8% of graft losses Disease recurrence after paediatric renal transplantation can be associated with a high or low risk of graft ...

Shares of Greenwich LifeSciences climbed after the company said its immunotherapy to prevent breast cancer recurrences showed a roughly 80% reduction in recurrence rate during a late-stage trial. The ...

Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...